Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Fried

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
American Journal of Hematology|July 1, 1995
Idiopathic CD4+ T-lymphocytopenia in HIV seronegative men with hemophilia and sex partners of HIV seropositive men. Multicenter Hemophilia Cohort StudyT R O'Brien, L Diamondstone, M W Fried, et al.
Hepatology (Baltimore, Md.)|May 1, 1997
Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and nonviral chronic liver diseaseM W Fried, Y E Khudyakov, G A Smallwood, et al.
The American Journal of Gastroenterology|November 1, 1993
A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis BA M Di Bisceglie, T L Fong, M W Fried, et al.
Hepatology (Baltimore, Md.)|September 1, 1992
A pilot study of ribavirin therapy for chronic hepatitis CA M Di Bisceglie, M Shindo, T L Fong, et al.
The American Journal of Gastroenterology|November 30, 2000
A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotypeM W Fried, M Shiffman, R K Sterling, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis CD Theodore, M W Fried, D E Kleiner, et al.
Journal of Virology|March 9, 2000
Sequence heterogeneity of TT virus and closely related virusesY E Khudyakov, M E Cong, B Nichols, et al.
Alimentary Pharmacology & Therapeutics|January 30, 2018
Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapyD M Evon, J Amador, P Stewart, et al.
Hepatology (Baltimore, Md.)|February 15, 2001
Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis CK R Reddy, T L Wright, P J Pockros, et al.
Alimentary Pharmacology & Therapeutics|January 29, 2015
Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevirR K Sterling, A Kuo, V K Rustgi, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
American Journal of Hematology|July 1, 1995
Idiopathic CD4+ T-lymphocytopenia in HIV seronegative men with hemophilia and sex partners of HIV seropositive men. Multicenter Hemophilia Cohort StudyT R O'Brien, L Diamondstone, M W Fried, et al.
Hepatology (Baltimore, Md.)|May 1, 1997
Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and nonviral chronic liver diseaseM W Fried, Y E Khudyakov, G A Smallwood, et al.
The American Journal of Gastroenterology|November 1, 1993
A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis BA M Di Bisceglie, T L Fong, M W Fried, et al.
Hepatology (Baltimore, Md.)|September 1, 1992
A pilot study of ribavirin therapy for chronic hepatitis CA M Di Bisceglie, M Shindo, T L Fong, et al.
The American Journal of Gastroenterology|November 30, 2000
A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotypeM W Fried, M Shiffman, R K Sterling, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis CD Theodore, M W Fried, D E Kleiner, et al.
Journal of Virology|March 9, 2000
Sequence heterogeneity of TT virus and closely related virusesY E Khudyakov, M E Cong, B Nichols, et al.
Alimentary Pharmacology & Therapeutics|January 30, 2018
Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapyD M Evon, J Amador, P Stewart, et al.
Hepatology (Baltimore, Md.)|February 15, 2001
Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis CK R Reddy, T L Wright, P J Pockros, et al.
Alimentary Pharmacology & Therapeutics|January 29, 2015
Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevirR K Sterling, A Kuo, V K Rustgi, et al.
Pageof 6